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Causative Mutations and Mechanism
of Androgenetic Hydatidiform Moles
Ngoc Minh Phuong Nguyen,1,15 Zhao-Jia Ge,1,15 Ramesh Reddy,1 Somayyeh Fahiminiya,1,2
Philippe Sauthier,3 Rashmi Bagga,4 Feride Iffet Sahin,5 Sangeetha Mahadevan,6 Matthew Osmond,1,2
Magali Breguet,3 Kurosh Rahimi,7 Louise Lapensee,8,9 Karine Hovanes,10 Radhika Srinivasan,11
Ignatia B. Van den Veyver,6 Trilochan Sahoo,10 Asangla Ao,1,12 Jacek Majewski,1,2 Teruko Taketo,12,13,14
and Rima Slim1,12,*
Androgenetic complete hydatidiformmoles are human pregnancies with no embryos and affect 1 in every 1,400 pregnancies. They have
mostly androgenetic monospermic genomes with all the chromosomes originating from a haploid sperm and no maternal chromo-
somes. Androgenetic complete hydatidiform moles were described in 1977, but how they occur has remained an open question. We
identified bi-allelic deleteriousmutations inMEI1, TOP6BL/C11orf80, and REC114, with roles inmeiotic double-strand breaks formation
in women with recurrent androgenetic complete hydatidiform moles. We investigated the occurrence of androgenesis inMei1-deficient
female mice and discovered that 8% of their oocytes lose all their chromosomes by extruding them with the spindles into the first polar
body. We demonstrate that Mei1/ oocytes are capable of fertilization and 5% produce androgenetic zygotes. Thus, we uncover a
meiotic abnormality in mammals and a mechanism for the genesis of androgenetic zygotes that is the extrusion of all maternal chro-
mosomes and their spindles into the first polar body.Introduction
Hydatidiform mole (HM) (MIM: 231090) is a human preg-
nancy with abnormal embryonic development and exces-
sive trophoblastic proliferation. The common form of HM
is sporadic, non-recurrent, and affects 1 in every 600 preg-
nancies.1 Based on microscopic morphological evaluation,
half of common HMs belong to the histological type of
partial HMs (PHMs) and have a triploid dispermic genome
with two sets of paternal chromosomes and one set of
maternal chromosomes. The second half belongs to the
histological type of complete HMs (CHMs) and has a
diploid androgenetic genome with all the chromosomes
originating from one (monospermic) or two sperms (dis-
permic) and no maternal chromosomes. CHMs affect
approximately 1 in every 1,400 pregnancies.1 Among
androgenetic CHMs (AnCHMs), monospermic ones ac-
count for 85% of the cases and dispermic ones for 15%
of the cases.2 Androgenetic monospermic CHMs were first
described in 1977,3 but the proposed mechanisms of their
occurrence remained hypothetical. It is believed that after
fertilization between a haploid sperm and an oocyte that
has lost its nuclear DNA (for simplicity referred hereafter
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 2018 American Society of Human Genetics.to reconstitute diploidy. Then, because the paternal and
maternal genomes have different roles in cellular prolifer-
ation and embryonic differentiation, the androgenetic
genome that results from such a zygote leads to the molar
phenotype. However, in decades of in vitro fertilization, no
one has seen or reported individuals who produced sys-
tematically empty oocytes.4 A new mechanism for the
origin of AnCHMs was suggested: that dispermic fertiliza-
tion of a haploid oocyte followed by postzygotic diploid-
ization is more likely to be at the origin of the different
genotypic types of sporadic HMs as well as of their associ-
ation with mosaicisms and twin pregnancies consisting of
one fetus with a normal placenta and a HM.4
Recurrent HMs (RHMs) affect 1.5%–9% of women with
a prior HM.5–10 There are two genes, NLRP7 (MIM:
609661)11 and KHDC3L (MIM: 611687),12 responsible for
RHMs. Bi-allelic mutations in these two genes explain
the etiology of RHMs in 60% of affected women.13 Recur-
rent molar tissues from women with bi-allelic mutations
in the two known genes are all diploid biparental while
those from women without mutations are heterogeneous.
Among women with no recessive mutations in the known
genes, a minority of women have diploid biparental RHMs,
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PHMs, and the second half have androgenetic monosper-
mic CHMs.13 Available data on women with diploid
androgenetic monospermic RHMs indicate that 17%–
37% of them fail to have live births, suggesting that these
women may have a strong genetic defect underlying their
RHMs.13,14
To identify mutations responsible for RHMs, we per-
formed whole-exome sequencing (WES) on a total of
65 women with RHMs (including all histopathological
and genotypic types), miscarriages, and infertility, who
were negative for mutations in NLRP7 and KHDC3L. We
identified bi-allelic deleterious mutations in meiotic dou-
ble-stranded break formation protein 1 (MEI1) (MIM:
608797), type 2 DNA topoisomerase 6 subunit B-like
(TOP6BL/C11orf80) (MIM: 616109), and REC114 meiotic
recombination (REC114) genes in five unrelated women,
of which two had other family members with recurrent
miscarriages and infertility. We demonstrated that their
HMs have the histopathological features of CHMs and
have androgenetic monospermic genomes. All three genes
are conserved during evolution and are known to play
roles during early homologous chromosome pairing and
recombination in the mouse oocyte.15–17 In vitro matura-
tion of oocytes from Mei1-deficient female mice has previ-
ously been reported, but the number of obtained mature
oocytes was very small and consequently, mature oocytes
were not further examined.15 In the current study, we
focused on the segregation of chromosomes at the first
meiotic division and the possibility of androgenetic em-
bryonic development. We confirm that most Mei1/ oo-
cytes have abnormal spindle morphology and misaligned
chromosomes on the spindles, and 63% of them fail to
extrude the first polar body (PB). However, 20% of oocytes
extruded morphologically abnormal first PB and some
extruded all their chromosomes together with the spindle
microtubules into the PB and were empty with no chromo-
somes.We demonstrate thatMei1/ oocytes are capable of
fertilization and that 5% lead to androgenetic zygotes. We
finally show that the zygotes derived from Mei1-deficient
oocytes are capable of initiating embryonic development
but mostly arrest at the 2- to 4-cell stage.Material and Methods
Subjects
Written informed consents were obtained from all participants
and the study was performed accordance to the McGill University
Research Ethics guidelines (Institutional Review Board # A01-M07-
98 03A). Blood or saliva from affected women and their family
members were collected. Genomic DNA was isolated from whole
blood cells using Flexigene DNA Kit (QIAGEN). The products of
conception from different pathology laboratories were retrieved
for genotype analysis.Mutation Analyses
Mutation analyses of NLRP7 and KHDC3L were performed to
exclude the presence of mutations in these two genes beforeThe Americansending for whole-exome sequencing. PCR conditions and the se-
quences of primers were previously described and samples were
sent for Sanger sequencing in both directions.11
Whole-Exome Sequencing
Whole-exome library preparation, capturing, sequencing, and bio-
informatics analyses were carried out at the McGill University and
Genome Quebec Innovation Center, Montreal, Canada as previ-
ously described.18 Whole exome was captured using either
SureSelect Human All Exon Kit version 5 (Agilent Technologies)
or the Roche Nimblegen SeqCap EZ Human Exome capture kit
on 3 mg or 500 ng gnomic DNA, respectively, and sequenced on
an Illumina HiSeq 2000 sequencer with paired-end 100-base pair
reads. The paired-end sequences were trimmed and aligned to
the human reference genome hg19 using BWA (v.0.5.9).19 The
Genome Analysis Toolkit (GATK)20 was used to perform local
realignment around small insertions and deletions (indels) and
to assess capture efficiency and coverage for all samples. The latter
was calculated after marking duplicate reads by Picard. Variants
were called individually for each individual using Samtools
(v.0.1.17)21 and annotated by Annovar.22 Subsequently, several
filtering criteria were applied to prioritize the potential causal var-
iants from non-pathogenic polymorphisms and sequence errors.
The variants were excluded when they were seen at a minor allele
frequency (MAF) greater than 0.01 in public databases (ExAC,
1000 Genomes, NHLBI exome databases) or in-house exomes
database (>1,000 exomes). Finally, only the most likely damaging
variants (nonsense, canonical splice-site, conserved missense, and
coding indels) were considered and manually examined in IGV23
if they were predicted to be deleterious by at least two bioinformat-
ics algorithms (PolyPhen, SIFT, MutationTaster, CADD-Combined
Annotation Dependent Depletion).
Sanger Sequencing Validation of Identified Mutations
Sanger sequencing was used to validate the mutations identified
by exome sequencing and to check the segregation of the
mutations in other family members. Primers were designed
using Primer Blast. PCR conditions and sequences of the
primers are provided in Table S1. Variant nomenclature is pro-
vided according to the GenBank references for MEI1 (GenBank:
NM_152513.3 and NP_689726.3), for TOP6BL/C11orf80
(GenBank: NM_024650.3 and NP_078926.3), and for REC114
(GenBank: NM_001042367.1 and NP_001035826.1).
Targeted Sequencing
The candidate genes were screened in additional affected women
with milder phenotypes (Table S3). MEI1 and REC114 were
screened in 99 affected women (of which 53 had at least 1 HM
and the remaining had R3 miscarriages). TOP6BL/C11orf80 was
screened in 246 affected women (46 women with at least 1 HM
and the remaining hadR3 miscarriages).
RT-PCR on Lymphoblastoid Cell Line and Human
Oocytes
RNAwas extracted from EBV-transformed lymphoblastoid cell line
(LCL) from affected women and controls using Trizol (Invitrogen).
Human oocytes at different stages (total 4–8 oocytes each stage)
were obtained from women undergoing IVF/ICSI and were
collected by removing the zona pellucida with acidified Tyrode’s
solution and washed in 13 PBS before putting them in lysis buffer
as previously described.24 cDNA synthesis was performed using aJournal of Human Genetics 103, 740–751, November 1, 2018 741
reverse transcription kit (Life Technologies, Thermo Scientific).
PCR conditions and primers for RT-PCR are provided in Table S1.
H&E Staining, p57KIP2 Immunohistochemistry, Flow
Cytometry, Microsatellite Genotyping, and SNP
Microarray Analysis
Sections of formalin-fixed, paraffin-embedded (FFPE) tissues were
prepared for H&E staining, p57KIP2 immunohistochemistry, flow
cytometry, and microsatellite genotyping as previously
described.13 Microarray analysis search for aneuploidies in prod-
ucts of conception of affected women was performed at Invitae
as previously described.25
Mice
Mei1 heterozygous mice (B6.129S1-Mei1m1Jcs/Mmnc)26 were
purchased from the MMRRC (Mutant Mouse Resource & Research
Centers Supported by NIH, USA) (MMRRC#31721), maintained
on the C57BL/6J background (Jackson Laboratory), and crossed
to produce homozygous null Mei1. Genotyping was done accord-
ing to the MMRRC protocol. The mice were fed in a temperature-
and light-controlled room at the Animal Resource Division of the
McGill University Health Centre Research Institute. All the pro-
cedures and ethics were approved by theMcGill University Animal
Care Committee in accordance with the Canadian Council on An-
imal Care. Food and water were provided ad libitum.
RT-PCR on Mouse Tissues
Ovaries, germinal vesicle-stage (GV) oocytes, and metaphase II
(MII) oocytes (total of 70–100 oocytes) were collected from
12.5 dpc (days postcoitum), 17.5 dpc, newborn, 5 dpp (days
postpartum), and adult wild-type females. Total RNAwas extracted
using the RNeasy plus Micro and Mini Kit (QIAGEN) according to
the manufacturer’s instructions. cDNA was synthesized (Invitro-
gen) and used as template for RT-PCR. b-actin was used as a con-
trol. The primers and conditions used for RT-PCR are provided in
Table S2. The transcript levels of genes were checked using 2%
agarose gel.
Mouse Oocyte Maturation In Vitro and In Vivo
For in vitro oocytematuration, femalemice at 25–27 dppwere intra-
peritoneally injected with 10 IU eCG (equine chorionic gonado-
tropin) per mouse. The mice were killed by cervical dislocation
46–48 hr later and the ovaries were collected to retrieve cumulus
cell-oocyte complexes (COCs). COCs were cultured in a-MEMme-
dium containing 5 IU/mL FSH (follicle-stimulating hormone,
Sigma), 5% HI-FBS (heat inactivated fetal bovine serum), 7.5 mL/
mL 1003 penicillin/streptomycin, and 0.25 mM sodium pyruvate
(GIBCO, Thermo-Fisher Sci) for 17 to 19 hr for all experiments27
except for the experiment to assess meiotic progression and delay.
For this experiment, maturation was extended to 24 hr of in vitro
culture. For in vivo oocyte maturation, females at 25–27 dpp were
intraperitoneally injected with 10 IU eCG, and 46–48 hr later,
with 7.5 IU hCG (human chorionic gonadotropin; Sigma) per
mouse. 15 hr later, oocytes were collected from oviduct ampullae.
Mouse Embryo Culture In Vitro
Hormonal treatment with dCG followed by hCG was done as
described above at 25–27 dpp and the females were left with
DBA/2 males (Charles River Laboratories) overnight. 20 hr after
hCG injection, zygotes were collected from oviduct ampullae
and cumulus cells were removed using 1% hyaluronidase. Washed742 The American Journal of Human Genetics 103, 740–751, Novemzygotes were used for immunofluorescence staining or cultured in
KSOM (Millipore) for 5 days under 5%CO2with humidity at 37
C.
Embryo development was recorded daily.
Immunofluorescence
Immunofluorescence staining was carried out as previously
described.28 Briefly, oocytes were fixed in 4% paraformaldehyde
(PFA) in PBS for 30 min and then transferred to membrane perme-
abilization solution (0.5% Triton X-100) in water for 20 min.
Thereafter, oocytes were blocked in 1% BSA (bovine serum
albumin) in PBS for 1 hr. The oocytes were then incubated with
primary antibodies diluted with 1% BSA overnight at 4C. After
incubation with secondary antibodies at room temperature for
1 hr, oocytes were placed in mounting medium with DAPI (Vec-
tor). Fluorescence was visualized using Zeiss LSM780 Scanning
Confocal Microscope at the Molecular Imaging Facility of the
Research Institute of the McGill University Health Centre.
Antibodies
The following antibodies were used; mouse-anti-H3K9me2 (1:50,
Abcam), mouse-anti-a-tubulin (1:100, Santa Cruz), and donkey-
anti-mouse IgG-Alexa fluor 488 (1:500, Invitrogen).
Live Imaging
COCs were cultured for maturation in a-MEM as previous
described for 12 hr, and then cumulus cells were removed using
1% hyaluronidase. The denuded oocytes were incubated with
5 ng/mL Hoechst 33342 in a-MEM supplemented as above
without FSH for 30 min. Thereafter, the oocytes were transferred
to Zeiss LSM780 Scanning Confocal Microscope to monitor the
first polar body extrusion, by scanning every 20 min, for 7 hr.Results
Identification of Bi-allelic Mutations in MEI1, TOP6BL/
C11orf80, and REC114
We performed WES on 65 women with RHMs (including
all histopathological and genotypic types) and without
mutations in NLRP7 or KHDC3L and 18 of their relatives.
After aligning the WES reads to the reference genome,
variants-calling, and filtering for rare variants with mi-
nor-allele frequency < 0.01, we analyzed the data under
the recessive mode of inheritance because of its compati-
bility with the inheritance of the disease in all reported
cases of RHMs (with or without mutations in the two
known genes). We identified rare bi-allelic deleterious
mutations (nonsense, canonical splice-site, evolutionary
conserved missense, and coding indel) in seven impor-
tant candidate genes. We next performed targeted
sequencing of the seven candidate genes on 99 to 246
women with milder defects (2 HMs or R3 miscarriages
with or without 1 HM) (from all genotypic types)
(Table S3). The two approaches led to the identification
of bi-allelic potentially deleterious mutations in three
genes in five unrelated affected women, including two
from familial cases.
In MEI1, exome sequencing revealed a novel homozy-
gous protein-truncating mutation in exon 28, c.3452G>Aber 1, 2018
Figure 1. Pedigree Structure, Reproductive Outcomes, and Mutation Analysis of Two Families with Bi-allelic MEI1 Mutations
(A) Sanger sequencing and segregation of the mutation identified in MEI1 in the family of proband 1333 (indicated by an arrow).
(B) RT-PCR demonstrating abnormal splicing caused by the nonsense mutation (c.3452G>A) and the generation of three cDNA frag-
ments, the normal fragment indicated by a black arrow and two abnormal fragments indicated by dashed red lines (a larger fragment
that includes intron 27 and a smaller fragment that skips exon 28).
(C) Sanger sequencing and segregation of the mutations identified in MEI1 in the family of proband 880 (indicated by an arrow).
(D) Abnormal splicing in affected individual 880 showing the amplification of a smaller cDNA fragment that corresponds to the skipping
of exon 11 (red arrow) and another cDNA fragment corresponding to the normal splicing isoform (black arrow). RNAwas from lympho-
blastoid cell lines (LCL) of the affected women.
(E) Schematic presentation of the domains of human andmouse MEI1. The positions of the mutations are indicated by arrows. The mu-
tations identified in this study are shown in red. In black is a recently reported mutation in two infertile brothers with non-obstructive
azoospermia. The mutation in the Mei1 knockout is shown on the mouse protein.(p.Trp1151*), in proband 1333 (Figure 1A, Table S4) with a
history of four miscarriages followed by four HMs, all
from spontaneous conceptions. In addition, she had
one failed cycle of in vitro fertilization by intra-cyto-
plasmic sperm injection (Table S5). Analyzing additional
samples from other family members identified the same
mutation in a homozygous state in two sisters who had
one and three miscarriages, respectively, and both under-
went total abdominal hysterectomy because of several
uterine fibroids. The mother of the three sisters was found
to be a heterozygous carrier of their mutation (Figure 1A).
Using RT-PCR on total RNA from a lymphoblastoid cell
line (LCL) from the proband 1333, we found that the
mutation leads to, in addition to the normal splicing iso-
form, two abnormal splicing isoforms: a larger cDNA frag-
ment caused by the insertion of intron 27 between exons
27 and 28 and a smaller cDNA fragment due to the skip-
ping of exon 28 (Figure 1B). This aberrant splicing wasThe Americanseen only in the affected woman and not in control sub-
jects and is most likely mediated by the nonsense-medi-
ated decay.29,30
The second family consists of a woman (proband 880)
with six miscarriages and one CHM and her brother, who
is infertile, with non-obstructive azoospermia and no
Y chromosome deletions. Both were found compound
heterozygous for an invariant splice site mutation,
c.1196þ1G>A, affecting the splice donor of exon 10, and
a 1-bp deletion, c.2206del (p.Val736Serfs*31), in exon 19
(Figure 1C, Table S4). The two mutations segregated in
the family, one from each parent. Using RT-PCR on total
RNA from a LCL from the proband 880, we found that
the invariant splice site mutation, c.1196þ1G>A, leads
to a smaller cDNA fragment that corresponds to the skip-
ping of exon 11 (Figure 1D) located in one of the two pre-
dicted Armadillo-type fold domains (Figure 1E). These two
mutations were identified in proband 880 by targetedJournal of Human Genetics 103, 740–751, November 1, 2018 743
Figure 2. Pedigree Structure, Reproductive Outcomes, and Mutation Analyses of TOP6BL/ C11orf80 and REC114 in Three Affected
Women with Bi-allelic Mutations
(A) Pedigree of proband 1031 showing the segregation of TOP6BL/C11orf80 mutations and the chromatograms.
(B) Pedigree of proband HM74 showing the chromatogram of her mutation in TOP6BL/C11orf80 and the conservation of the changed
amino acid in different species by multiple alignment from NCBI.
(C) Pedigree of proband 978 with REC114 mutation and the chromatograms.sequencing and then in her other family members by
Sanger sequencing.
In TOP6BL/C11orf80, we found in one woman (ID
1031), with one miscarriage and two HMs, a 1-bp inser-
tion, c.783dup (p.Glu262*) in a homozygous state
(Figure 2A, Table S4). The mutation segregated from both
parents who were found to be heterozygous carriers. In a
second woman with RHMs (ID HM74, previously reported
as the affected woman 231), we found a homozygous
missense variant c.1501T>C (p.Ser501Pro) that affects a
highly conserved amino acid (PolyPhen ¼ 0.9, CADD ¼
22.5) (Figure 2B, Table S4). The c.783dup mutation leads
to the truncation of the protein before the transducer
domain. The second mutation, c.1501T>C (p.Ser501Pro),
affects a conserved amino acid residue also involved in
the interaction of TOP6BL transducer domain with
SPO11, a component of topoisomerase 6 complex required
for the formation of double-strand breaks in mice.16 These
two mutations in TOP6BL were identified by exome
sequencing.
In REC114, using exome sequencing, we found in one
woman (ID 978) with a miscarriage and three CHMs a744 The American Journal of Human Genetics 103, 740–751, Novemnovel splice acceptor mutation, c.3341G>A, in a homo-
zygous state (Figure 2C, Table S4). Of note that the last
CHM of this woman was conceived with the help of intra-
uterine insemination because of her infertility. We did not
detect REC114 transcripts in LCL and consequently could
not check the effect of this mutation on gene splicing.
The mutation segregated in the family and the two parents
were found to be heterozygous carriers (Figure 2C).
MEI1, TOP6BL/C11orf80, and REC114 are conserved
from yeast to human and their functions have been exam-
ined in several organisms including yeast,31,32 plants,33
worms,34 and mice.15–17 It was striking to see that all three
genes play a key role in the formation of double-strand
breaks, which is essential for homologous chromosome
synapsis and recombination during meiosis I. Mutations
in these three genes have never been reported in any
human disease with the exception of a recent case of two
infertile brothers with a homozygous bi-allelicMEI1muta-
tion.35 Therefore, the presence of bi-allelic mutations in
five unrelated women and three affected siblings estab-
lishes their causal role in recurrent HMs and miscarriages,
and in male and female infertility in humans.ber 1, 2018
Affected Women with Bi-allelic MEI1 Mutations Have
AnCHMs
We next retrieved all HM tissues from affected women
1333 and 880 with MEI1 mutations and comprehensively
analyzed them. By morphological evaluation, all tissues
fulfilled the histopathological criteria of CHMs, did not ex-
press p57KIP2 in the nuclei of the cytotrophoblast and
villous mesenchyme cells, were diploid by flow cytometry,
androgenetic monospermic bymicrosatellite DNAmarkers
genotyping, and did not have aneuploidies by SNP micro-
arrays (Figures S1–S4). Two CHM tissues from affected
woman 978, with bi-allelic REC114mutations, were geno-
typed by the referring laboratory and found androgenetic
monospermic. The tissues from affected woman HM74,
with bi-allelic mutations in TOP6BL/C11orf80, were re-
ported to be most likely androgenetic CHMs.36 Therefore,
HMs from affected women with mutations in the three
genes are androgenetic and have a different mechanism
at their origin than HMs from women with bi-allelic muta-
tions in NLRP7 or KHDC3L.
A complete hCG follow up after HM evacuation was
available for affected women 880 and 1031 and both had
low risk persistent trophoblastic diseases after the last
conception. The non-molar miscarriages of all affected
women with mutations in the three genes did not require
dilatation and curettage and therefore are not available for
evaluation.
Taken together, these data indicate that the bi-allelic mu-
tations in three genes we identified may not be responsible
only for recurrent androgenetic CHMs, but also for recur-
rent miscarriages and female and male infertility.
Expression of Mei1, Top6bl /C11orf80, and Rec114
In humans, the three genes are transcribed in ovaries and
some other somatic tissues (Figures 1B and S5A) but were
not detected in oocytes (4–8 oocytes per sample). In
mice, the three genes were detected in ovaries from embry-
onic day 12 to 5 days postpartum (dpp) (Figure S5B), and
these data are in agreement with a previous report.26While
Top6bl and Rec114 were found expressed in germinal vesi-
cles (GV) and metaphase II (MII) oocytes from 25 dpp
mice, Mei1 expression was not detectable in GV or MII
mouse oocytes (70–100 oocytes per sample).
Evidence of Empty Oocytes from Null Mei1 Females
In humans, it is unknown how an androgenetic mono-
spermic CHM forms and such an entity has never been re-
ported in animals. To elucidate the mechanism(s) leading
to androgenetic monospermic CHM and possibly model
some of its features in mice, we used a mouse knockout
for Mei1 that was available when we identified the
mutations in the affected women.15 The mutation in the
Mei1 knockout (c.9842A>T) is very close to one of the
mutations, p.Val736Serfs*31, found in proband 880
(Figure 1E), and results in two abnormal splice isoforms
which are predicted to lead to premature stop codons.
Mei1/ males and females are infertile, but otherwiseThe Americanhealthy.15 While the males have no spermatozoa in their
testes, the females have oocytes in all follicular stages at
young ages, albeit in reduced numbers. The development
of oocytes during in vitromaturation has been reported for
Mei1/ and it was found that 94% of the oocytes arrest
at metaphase I and have abnormal spindles with mis-
aligned chromosomes scattered on the spindles; only 6%
of Mei1/ oocytes progress to metaphase II and extrude
the first PB. To better understand the mechanism of
AnCHM formation, we compared the development of
oocytes from Mei1/ with those of wild-type after
in vitro maturation. Under our experimental condi-
tions of in vitromaturation for 17–24 hr, we found that oo-
cytes from Mei1/ have delayed meiotic progression
(Figure 3A). We found that 96% of oocytes from the
wild-type and only 8% of oocytes from Mei1/ extruded
the first PB of normal size and shape. However, 63% of oo-
cytes from Mei1/ failed to extrude the first PB; 20%
extruded abnormal PB, either one PB of normal size and
with a rough surface, one large PB, or two PBs (despite
not being fertilized); the remaining 6% of oocytes
appeared to be 2- to 4-cell-like or degenerating (Figures
3B–3D). These PB abnormalities were also observed in
in vivo matured Mei1/ oocytes (Figure 3D) with the
exception that more oocytes were seen without PB in
both mutant and wild-type, probably because the first
PB had degenerated, a well-documented phenomenon of
in vivo maturation.37
We next examined the spindle morphology and chro-
mosome congregation in the in vitro matured oocytes us-
ing immunofluorescence localization of a-tubulin and
DAPI staining of the chromosomes. We found that all oo-
cytes without PB had chromosomes, but the chromosomes
were misaligned on the spindles of abnormal shapes
(Figure 4B). Of the oocytes that extruded PB, approxi-
mately 70% appeared at telophase, i.e., the spindles were
seen between the two sets of chromosomes without clear
separation between the oocytes and the PB. Some oocytes
with two PBs had tripolar spindles with chromosomes at
each pole and two of them forming two first PBs (Figures
4C and 4D). Other oocytes had bipolar spindles with chro-
mosomes at both ends, but both the spindles and the chro-
mosomes at their poles were altogether extruded into
the first PB leaving the oocytes with few chromosomes
(Figure S6) or empty with no chromosomes (Figures 4D–
4F). Empty oocytes were also observed in in vivo matured
oocytes (Figure S7). Such empty oocytes were observed
only among those that extruded abnormal PB and ac-
counted for approximately 8% of oocytes with R1 PB
matured in vitro or in vivo. Empty oocytes were not
observed in wild-type or Mei1þ/ mice after either in vitro
or in vivo maturation. In addition, we did not see spindles
or chromosomes congregation abnormalities in oocytes
from Mei1þ/, which behaved like those from wild-type
mice. Using live imaging, wemonitored in vitromaturation
of oocytes fromMei1/ and confirmed the extrusion of all
the chromosomes into the PB in some oocytes (Video S1).Journal of Human Genetics 103, 740–751, November 1, 2018 745
Figure 3. Meiosis I Abnormalities in Oocytes from Wild-Type, Heterozygous, and Homozygous Mice
(A) Fully grown oocytes fromMei1þ/þ andMei1/mice were cultured in vitro and the frequency of various stages at different time point
were recorded by phase contrast microscopy. The absence of polar body (PB) 17–19 hr after germinal vesicle (GV) breakdown was our
criterion for arrest before metaphase I stage (MI) and the presence of at least one PB was our criterion for progression to metaphase II
arrest (MII).
(B) Percentages of oocytes with or without abnormalities observed after in vitro maturation.
(C) Numbers (N) of oocytes with various PB abnormalities observed after in vitro maturation.
(D) Examples of oocytes with abnormal polar bodies after in vitro or in vivo maturation.Evidence of Androgenetic Zygotes from Null Mei1
Oocytes
We next asked whether oocytes from null Mei1/ are
capable of fertilization. Because the rate of fertilization
and embryonic development in vitro is lower than in vivo,
we used superovulation and natural mating in all subse-
quent experiments of embryonic development. To distin-
guishmaternal from paternal chromosomes in the zygotes,
we used immunofluorescence with an antibody against di-
methylated histone 3 at lysine 9 (H3K9me2). H3K9me2 is
an epigenetic marker that is acquired during oogenesis, but
not during spermatogenesis; consequently, it distinguishes
maternal from paternal chromosomes up to pronuclear
fusion in late zygotes.38 We first confirmed similar immu-
nofluorescence staining of H3K9me2 between wild-type
and Mei1/ oocytes at GV to MII stages (Figure 5A). We
next examined the oocytes after fertilization and
confirmed that H3K9me2 stains only the maternal but
not paternal chromosomes in control zygote (Figure S8).
Among the 113 oocytes from Mei1/ females analyzed,
68 (60%) had evidence of fertilization and contained
paternal DNA. Some zygotes were penetrated by cumulus
cells (Figures S9 and S10) and such zygotes were fertilized
by two or three spermatozoids. Among all the zygotes,
approximately 5% were androgenetic and did not contain
maternal chromosomes. Figure 5B shows a zygote that had746 The American Journal of Human Genetics 103, 740–751, Novemlost all maternal DNA into the PB (positive for anti-
H3K9me2) and started the first mitotic division of the
male pronucleus. All z axis stack sections of this zygote
are shown in Video S2. We also observed zygotes that
had retained very few maternal chromosomes and others
that had undergone asymmetrical cleavage into 2-cell-
like, with one cell containing paternal pronucleus or sperm
head and the other containing maternal pronucleus
(Figure S11).
Zygotes from Null Mei1 Oocytes Can Initiate Embryonic
Development
We next investigated whether the zygotes derived from
Mei1/ oocytes can initiate embryonic development. We
crossed Mei1/ females with wild-type males overnight,
collected oocytes, and monitored their daily development
in culture for up to 5 days using phase contrast microscopy
(Figure 6). Our analysis demonstrated that 72% of embryos
(n ¼ 200) derived from Mei1/ females underwent cleav-
age, but most were arrested at the 2-cell or 4-cell stage,
only 2% reached the blastocyst stage after 120 hr post-
fertilization, and none hatched (Figure 6). For comparison,
78% of oocytes from wild-type mice reached the blastocyst
stage 96 hr post-fertilization and all hatched. In conclu-
sion, oocytes from Mei1/ females can be fertilized and
undergo embryonic development but their chance tober 1, 2018
Figure 4. Various Spindle and Chromo-
some Congression Abnormalities after
In Vitro Maturation
(A) Oocyte from wild-type at MII display-
ing two normal spindles, one in the oocyte
with aligned chromosomes and another in
the polar body (PB).
(B) An oocyte from Mei1/ with tripolar
spindles within the oocyte and misaligned
chromosomes.
(C) An oocyte from Mei1/ with tripolar
spindles that had extruded DNA at two
poles into the PB (arrows).
(D) An empty oocyte from Mei1/ that
had extruded the spindles and the chro-
mosomes at their two poles into two PB
(arrows).
(E) Another empty oocyte from Mei1/
that had extruded all its DNA with the
spindles into the PB (arrows).
(F) An oocyte that extruded one large
(large arrow) and two normal-size PB
(small arrows).reach the stage for implantation is limited. Their develop-
ment in uterus or on the genetic background other than
C57/B6 remains an open question.Discussion
Here we provide evidence implicating bi-allelic mutations
in three genes, MEI1, TOP6BL, and REC114, in the causa-
tion of recurrent androgenetic monospermic hydatidiform
moles, miscarriages, and infertility in humans. This evi-
dence is based on the identification of bi-allelic mutations
inMEI1 in two familial case subjects, in TOP6BL in two un-
related women, and in REC114 in one woman. The impli-
cation of REC114 is also based on the known interaction of
its protein with MEI4, an interactor of MEI1 in yeast and
mice.17,32 These three genes have been studied in various
organisms and model systems and all are required for dou-
ble-strand breaks formation in the early phase ofmeiosis in
oocytes. Analyzing five HMs from two unrelated women
with MEI1 mutations demonstrated that the five tissuesThe American Journal of Human Genetfulfill the histopathological criteria
of CHMs, lack p57KIP2 expression,
and have diploid androgenetic mono-
spermic genomes. Tissues from pro-
band 978 with mutations in REC114
were referred to us as androgenetic
monospermic CHMs and those from
woman HM74, with mutations in
TOP6BL, are believed to be androge-
netic CHMs. Taken together, these
data establish the role of MEI1, and
possibly the two other genes, in the
genesis of androgenetic CHMs.
Among the three identified genes,
Mei1 is the most studied and itsfunctional role has been investigated in several spe-
cies,15,31,33,34 of which mouse is the closest, evolution-
arily, to human. Null mouse mutants fail to complete
the first meiotic division due to defective double-strand
breaks formation. MEI1 was the first of the three genes,
in which we found mutations in two unrelated families,
and we were able to access the HM tissues and demon-
strate their androgenetic monospermic genomes, so we
set out to investigate whether androgenetic pregnancies
or conceptions occur in Mei1-null mice. Because Mei1-
null female mice were documented to be infertile, we
hypothesized that perhaps androgenesis occurs in them
but such conceptions do not implant and lead to detect-
able pregnancies. We asked three main questions. (1) Do
Mei1-deficient females produce empty oocytes with no
maternal chromosomes? (2) When do Mei1-deficient
oocytes lose their chromosomes, before or after fertiliza-
tion? (3) By which mechanism do Mei1-deficient oocytes
lose their chromosomes? To answer these questions,
we followed the development of oocytes from null Mei1
in in vitro maturation. We found that 8% of Mei1/ics 103, 740–751, November 1, 2018 747
Figure 5. H3K9me2 Staining of Maternal Chromosomes in Oocytes and Zygotes from Wild-Type and Mei1/
(A) H3K9me2 immunofluorescence of GVandMII oocytes from wild-type andMei1/ females, demonstrating that H3methylase is not
impaired in Mei1-deficient oocytes.
(B) H3K9me2 immunofluorescence on zygotes showing the staining of maternal but not paternal chromosomes in a zygote from
Mei1/ females. GV stands for germinal vesicle; MII, metaphase II; PB, polar body; ZP, zona pellucida; \, maternal chromosomes; _,
paternal chromosomes; and DIC, differential interference contrast.extruded all their chromosomes together with the spin-
dles into the first PB. Our results are in agreement with
some observations made on null mei1 in C. elegans,
which either fail to produce PBs, produce PBs with vari-
able numbers of maternal chromosomes, or produce large
PBs appearing to contain all maternal chromosomes.34,39
Furthermore, we showed that the oocytes from Mei1-null
females can be fertilized and 5% of the zygotes had lost
all their maternal chromosomes into the PBs, and were
therefore androgenetic. In addition, some of the zygotes
retained very few maternal chromosomes, which may
be unable to fuse with the paternal pronucleus and result
also in androgenetic embryos. From our analysis, another
potential mechanism that would lead to androgenesis
may occur during postzygotic cleavage of a fertilized
nucleated oocyte, resulting in the separation of paternal
DNA into one cell and maternal DNA into another
(Figure S11). Such aberrant cells with different genomes
may have different growth rates, be subject to some selec-
tion, and lead to mosaic conceptions including AnCHMs.
However, based on our observations, such events are
unlikely to be at the origin of RHMs in women with
MEI1 mutations because they were not recurrent in
Mei1-deficient females. Some of the androgenetic zygotes
we observed had cumulus cells under the zona pellucida,
which indicates its abnormal permeability; indeed, some748 The American Journal of Human Genetics 103, 740–751, Novemof these eggs were fertilized by two or three spermatozoa.
This suggests that androgenetic dispermic CHMs, known
to account for approximately 15% of sporadic androge-
netic CHMs,2 may involve the same mechanism and
occur also in conceptions from women with bi-allelic
MEI1 mutations.
The earliest defect that has been demonstrated in the
oocytes from Mei1/ and Top6bl/ is the impaired dou-
ble-strand breaks formation, which is essential for ho-
mologous chromosome synapsis and recombination.
The absence of synapsis renders the meiotic silencing of
unsynapsed chromatin regions, named MSUC, and af-
fects subsequent meiotic processes depending on the
silenced gene repertoire.40–43 Consequently, Mei1/ oo-
cytes may have accumulated several defects including
deficiency in cytoplasmic components in addition to
chromosomes segregation errors. In humans, the MSUC
can also be triggered by abnormal homologous chromo-
some synapsis in carriers of reciprocal translocations,
which are well documented to be associated with infer-
tility and recurrent miscarriages in male and female
carriers.44–46 With respect to HMs, two of the original re-
ports about androgenetic monospermic CHMs found
that 4%–6% of affected women had balanced chromo-
somal translocations, which is higher than the frequency
of reciprocal translocation in the general populationber 1, 2018
Figure 6. Preimplantation Development of Mei1/ Oocytes in Culture
Zygotes were collected from wild-type or Mei1/ females 20 hr after hCG injection and mating with wild-type males and cultured
in vitro. Embryonic development was analyzed daily using phase contrast microscopy. The embryos that failed to develop by the
next day were removed for further analysis. Embryos derived from Mei1/ oocytes were arrested mainly at the 2- to 4-cell stage.
A few reached the morula or blastocyst stages but appeared disorganized and none hatched.(0.6%).3,47 Miscarriages are a well-known risk factor for
sporadic HMs48 and sporadic HMs are more frequent in
women with recurrent miscarriages than in women
from the general population.49,50 However, only weak as-
sociations have been reported between infertility prob-
lems, difficulties in conception, and irregular menstrual
cycles and CHMs,51,52 which may need to be revisited
in the light of our findings. In Mei1-null oocytes, the
spectrum of abnormalities ranged from oocytes with
normal appearing chromosome complement (that would
lead to euploid conceptions or aneuploid conceptions
involving few chromosomes) to oocytes with few chro-
mosomes (that would lead to severely aneuploid concep-
tions that may not survive implantation and lead to
infertility) and empty oocytes (that would lead to andro-
genetic HMs), which support the commonalties between
HM, miscarriages, and infertility observed in our affected
women. In addition to the role of normal Mei1 in double-
strand breaks formation, in C. elegans, mei1 has been
shown to have a role in microtubule-severing activity
similar to katanin;53,54 consequently, its bi-allelic muta-
tions may have prevented the disassembly of microtu-
bules and the separation of the two sets of chromosomes
at the spindle poles and favored their extrusion alto-
gether into the PB. Investigating the possible occurrence
of empty oocytes in null mice for Top6bl and Rec114,
with no known roles in microtubule disassembly, will
help clarifying which Mei1 function is most likely at
the origin of the extrusion of the oocyte chromosomes
and spindles into the PB.
In conclusion, we unravel a mechanism, i.e., the extru-
sion of all the oocytes chromosomes with their spindles
into the first PB, for the genesis of androgenetic zygotes
in mammals and therefore a plausible mechanism for the
genesis of AnCHMs in humans.
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